Piramal Life Sciences
BSE: 532979 | NSE: PIRLIFE | ISIN: INE122J01015 | Pharmaceuticals
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes To Accounts
- Accounting Policy
- Finished Products
- Raw Materials
| Auditor's Report | Year End : Mar '09 |
1. We have audited the attached Balance Sheet of Piramal Life Sciences
Limited, as at March 31, 2009, and the related Profit and Loss Account
and Cash Flow Statement for the year ended on that date annexed
thereto, which we have signed under reference to this report. These
financial statements are the responsibility of the Companys
management. Our responsibility is to express an opinion on these
financial statements based on our audit.
2. We conducted our audit in accordance with the auditing standards
generally accepted in India. Those Standards require that we plan and
perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts
and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statements
presentation. We believe that our audit provides a reasonable basis for
our opinion.
3. As required by the Companies (Auditors Report) Order, 2003, as
amended by the Companies (Auditors Report) (Amendment) Order, 2004,
issued by the Central Government of India in terms of sub-section (4A)
of Section 227 of The Companies Act, 1956 of India (the Act) and on
the basis of such checks of the books and records of the Company as we
considered appropriate and according to the information and
explanations given to us, we give in the Annexure, a statement on the
matters specified in paragraphs 4 and 5 of the said Order.
4. Further to our comments in the Annexure referred to in paragraph 3
above, we report that:
(a) Without qualifying our report, attention is drawn to Note 3 of
Schedule 17 regarding preparation of accounts on a going concern basis
although the net-worth of the Company is fully eroded, taking into
account various finance options, future projections received from the
management and its future cash flow from development of molecules. The
Company is also considering other options, strategic funding,
partnership / outsourcing of development of molecules. Also, the
Company is in process of arranging long term finance to meet its
requirement. Accordingly, adjustment, if any, is not required to be
made to the assets of the Company.
(b) We have obtained all the information and explanations, which to the
best of our knowledge and belief were necessary for the purposes of our
audit;
(c) In our opinion, proper books of account as required by law have
been kept by the Company so far as appears from our examination of
those books;
(d) The Balance Sheet, Profit and Loss Account and Cash Flow Statement
dealt with by this report are in agreement with the books of account;
(e) In our opinion, the Balance Sheet, Profit and Loss Account and Cash
Flow Statement dealt with by this report comply with the accounting
standards referred to in sub-section (3C) of Section 211 of the Act;
(f) On the basis of written representations received from the
directors, as on March 31, 2009 and taken on record by the Board of
Directors, none of the directors is disqualified as on March 31, 2009
from being appointed as a director in terms of clause (g) of
sub-section (1) of Section 274 of the Act;
(g) In our opinion and to the best of our information and according to
the explanations given to us, the said financial statements together
with the notes thereon and attached thereto give in the prescribed
manner the information required by the Act and give a true and fair
view in conformity with the accounting principles generally accepted in
India: (i) in the case of the Balance Sheet, of the state of affairs of
the Company as at March 31, 2009; (ii) in the case of the Profit and
Loss Account, of loss for the year ended on that date; and (iii) in the
case of the Cash Flow Statement, of the cash flows for the year ended
on that date.
ANNEXURE TO AUDITORS REPORT
[Referred to in paragraph 3 of the Auditors Report of even date to the
members of Piramal Life Sciences Limited on the financial statements
for the year ended March 31, 2009]
1. (a) The Company is maintaining proper records showing full
particulars including quantitative details and situation of fixed
assets.
(b) The fixed assets are physically verified by the management
according to a phased programme designed to cover all the items over a
period of three years, which in our opinion, is reasonable having
regard to the size of the Company and the nature of its assets.
Pursuant to the programme, a portion of the fixed assets has been
physically verified by the management during the year and no material
discrepancies between the book records and the physical inventory have
been noticed.
(c) In our opinion and according to the information and explanations
given to us, a substantial part of fixed assets has not been disposed
of by the Company during the year.
2. (a) The inventory (excluding stocks with third parties) has been
physically verified by the management during the year. In respect of
inventory lying with third parties, these have been confirmed by them.
In our opinion, the frequency of verification is reasonable.
(b) In our opinion, the procedures of physical verification of
inventory followed by the management are reasonable and adequate in
relation to the size of the Company and the nature of its business.
(c) On the basis of our examination of the inventory records, in our
opinion, the Company is maintaining proper records of inventory. The
discrepancies noticed on physical verification of inventory as compared
to book records were not material and have been properly dealt with in
the books of account.
3. (a) The Company has granted unsecured loan, to one Company covered
in the register maintained under Section 301 of the Act. The maximum
amount involved during the year and the year-end balance of such loan
aggregates to Rs. 1000 lakhs and Rs. Nil respectively.
(b) In our opinion, the rate of interest and other terms and conditions
of such loan is not prima-facie prejudicial to the interest of the
Company.
(c) In respect of the aforesaid loan, the party is repaying the
principal amount as stipulated and is also regular in payment of
interest, where applicable.
(d) In respect of the aforesaid loans granted, there is no overdue
amount more than Rupees One Lakh.
(e) The Company has taken unsecured loan, from one Company covered in
the register maintained under Section 301 of the Act. The maximum
amount involved during the year and the year end balance of such loan
aggregates to Rs. 7,769 lakhs and Rs. Nil respectively.
(f) In our opinion, the rate of interest and other terms and conditions
of such loan is not prima facie prejudicial to the interest of the
Company.
(g) In respect of the aforesaid loans, the Company is regular in
repaying the principal amounts as stipulated and is also regular in
payment of interest.
4. In our opinion and according to the information and explanations
given to us, having regard to the explanation that certain items
purchased, sold and services received are of special nature for which
suitable alternative sources do not exist for obtaining comparative
quotations, there is an adequate internal control system commensurate
with the size of the Company and the nature of its business for the
purchase of inventory and fixed assets and for sale of goods and
services. Further, on the basis of our examination of the books of
account and records of the Company, and according to the information
and explanations given to us, we have neither come across nor have been
informed of any continuing failure to correct major weaknesses in the
aforesaid internal control system.
5. (a) In our opinion and according to the information and
explanations given to us, the particulars of contracts or arrangements
referred to in Section 301 of the Act have been entered in the register
required to be maintained under that section.
(b) In our opinion and according to the information and explanations
given to us, the transactions made in pursuance of such contracts or
arrangements and exceeding the value of Rupees Five Lakhs in respect of
any party during the year have been made at prices which are reasonable
having regard to the prevailing market prices at the relevant time.
6. The Company has not accepted any deposits from the public within
the meaning of Sections 58A and 58AA of the Act and the rules framed
there under.
7. In our opinion, the Company has an internal audit system
commensurate with its size and nature of its business.
8. The Central Government of India has not prescribed the maintenance
of cost records under clause (d) of sub-section (1) of Section 209 of
the Act for any of the products of the Company.
9. (a) According to the information and explanations given to us and
the records of the Company examined by us, in our opinion, the Company
is generally regular in depositing the undisputed statutory dues
including Provident Fund, Investor Education and Protection fund,
Employees State Insurance, Income-tax, Sales-Tax, Wealth Tax, Service
Tax, Customs Duty, Excise Duty, Cess and other material statutory dues
as applicable, with the appropriate authorities in India.
(b) According to the information and explanations given to us and the
records of the Company examined by us, there are no dues of Income tax,
Sales tax, Wealth tax, Service tax, Customs Duty, Excise Duty and Cess
which have not been deposited on account of any dispute.
10. The Company has accumulated losses as at March 31, 2009 and it has
incurred cash losses in the financial year ended on that date and in
the immediately preceding financial year.
11. According to the records of the Company examined by us and the
information and explanations given to us, the Company has not defaulted
in repayment of dues to any bank as at the balance sheet date.
12. The Company has not granted any loans and advances on the basis of
security by way of pledge of shares, debentures and other securities.
13. The provisions of any special statute applicable to chit fund /
nidhi / mutual benefit fund/societies are not applicable to the
Company.
14. In our opinion, the Company is not a dealer or trader in shares,
securities, debentures and other investments.
15. In our opinion and according to the information and explanations
given to us, the Company has not given any guarantee for loan taken by
others from banks or financial institutions during the year.
16. In our opinion, and according to the information and explanations
given to us, on an overall basis, the term loans have been applied for
the purposes for which they were obtained.
17. According to the information and explanations given to us and on
an overall examination of the balance sheet of the Company, we report
that the Company has used funds of Rs. 7,777 lakhs raised on short-term
basis for long-term investment.
18. The Company has not made any preferential allotment of shares to
parties and companies covered in the register maintained under Section
301 of the Act during the year.
19. The Company has not issued any debentures.
20. The Company has not raised any money by public issues during the
year.
21. During the course of our examination of the books of account and
records of the Company, carried out in accordance with the generally
accepted auditing practices in India, and according to the information
and explanations given to us. we have neither come across any instance
of material fraud on or by the Company, noticed or reported during the
year, nor have we been informed of such case by the management.
Partha Ghosh
Partner
Membership Number F-55913
For and on behalf of
Price Waterhouse & Co.
Mumbai, Dated: April 25, 2009 Chartered Accountants |
|
![]() | |
| Source : Religare Technova | |
![]() | |




Online










